...
首页> 外文期刊>BMC Neurology >Management of oral anticoagulation after cardioembolic stroke and stroke survival data from a population based stroke registry (LuSSt)
【24h】

Management of oral anticoagulation after cardioembolic stroke and stroke survival data from a population based stroke registry (LuSSt)

机译:心脏栓塞性中风后的口服抗凝治疗以及基于人群的中风登记系统(LuSSt)的中风生存数据

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Cardioembolic stroke (CES) due to atrial fibrillation (AF) is associated with high stroke mortality. Oral anticoagulation (OAC) reduces stroke mortality, however, the impact of OAC-administration during hospital stay post ischemic stroke on mortality is unclear. We determined whether the timing of OAC initiation among other prognostic factors influenced mortality after CES. Methods Within the Ludwigshafen Stroke Study (LuSSt), a prospective population-based stroke register, we analysed all patients with a first ever ischemic stroke or TIA due to AF from 2006 until 2010. We analysed whether treatment or non-treatment with OAC and initiation of OAC-therapy during and after hospitalization influenced stroke mortality within 500 days after stroke/TIA due to AF. Results In total 479 patients had a first-ever ischemic stroke (n = 394) or TIA (n = 85) due to AF. One-year mortality rate was 28.4%. Overall, 252 patients (52.6%) received OAC. In 181 patients (37.8%), OAC treatment was started in hospital and continued thereafter. Recommendation to start OAC post discharge was given in 110 patients (23.0%) of whom 71 patients received OAC with VKA (14.8%). No OAC-recommendation was given in 158 patients (33.0%). In multivariate Cox regression analysis, higher age (HR 1.04; 95% CI 1.02-1.07), coronary artery disease (HR: 1.6; 95% CI 1.1-2.3), higher mRS-score at discharge (HR 1.24; 95% CI 1.09-1.4), and OAC treatment ((no OAC vs started in hospital (HR: 5.4; 95% CI 2.8-10.5), were independently associated with stroke mortality. OAC-timing did not significantly influence stroke mortality (started post discharge vs. started in hospital (HR 0.3; 95% CI 0.07-1.4)). Conclusions OAC non-treatment is the main predictor for stroke mortality. Although OAC initiation during hospital stay showed a trend towards higher mortality, early initiation in selected patients is an option as recommendation to start OAC post hospital was implemented in only 64.5%. This rate might be elevated by implementation of special intervention programs.
机译:背景由于房颤(AF)引起的心脏栓塞性中风(CES)与中风死亡率高相关。口服抗凝药(OAC)可以降低卒中死亡率,但是,尚不清楚缺血性卒中后住院期间OAC给药对死亡率的影响。我们确定了OAC启动的时机以及其他预后因素是否影响了CES后的死亡率。方法在路德维希港中风研究(LuSSt)中,这是一项基于人群的中风前瞻性研究,我们分析了2006年至2010年间因房颤而首次发生缺血性中风或TIA的所有患者。住院期间和之后的OAC疗法影响了因AF而导致卒中/ TIA后500天内的卒中死亡率。结果总共有479例患者因房颤首次出现缺血性卒中(n = 394)或TIA(n = 85)。一年死亡率为28.4%。总体上,有252名患者(52.6%)接受了OAC。在医院开始了OAC治疗的181例患者(37.8%),此后继续进行。建议110例患者(23.0%)出院后开始OAC,其中71例接受VKA的OAC患者(14.8%)。 158例患者(33.0%)没有推荐OAC。在多因素Cox回归分析中,年龄较高(HR 1.04; 95%CI 1.02-1.07),冠心病(HR:1.6; 95%CI 1.1-2.3),出院时mRS评分较高(HR 1.24; 95%CI 1.09) -1.4)和OAC治疗((没有OAC与开始住院治疗(HR:5.4; 95%CI 2.8-10.5))独立地与卒中死亡率相关。OAC定时对卒中死亡率没有显着影响(出院后开始vs.结论:不进行OAC治疗是卒中死亡率的主要预测指标,尽管在住院期间开始OAC呈死亡率上升趋势,但部分患者应尽早开始治疗(HR 0.3; 95%CI 0.07-1.4)。因为建议仅在64.5%的地方实施OAC住院后的建议,而实施特殊干预计划可能会提高这一比率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号